OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF SUBRETINAL FIBROSIS IN AGE-RELATED MACULAR DEGENERATION
暂无分享,去创建一个
Alexandra Miere | Giuseppe Querques | Oudy Semoun | Camille Jung | E. Souied | Salomon Y. Cohen | G. Querques | C. Jung | Eric H Souied | A. Miere | O. Semoun | A. El Ameen | H. Oubraham | Hassiba Oubraham | M. Srour | Ala'a El Ameen | Salomon Yves Cohen | Mayer Srour | S. Cohen
[1] Mbbs Md FRCPath Donald N. Pritzker Vinay Kumar. Robbins and Cotran pathologic basis of disease , 2015 .
[2] L. Ellis,et al. Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] Gabriel Coscas,et al. Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. , 2007, American journal of ophthalmology.
[4] P. Rosenfeld,et al. Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials. , 2011, Ophthalmology.
[5] Susan Schneider,et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.
[6] R. Tadayoni,et al. CAUSES OF UNSUCCESSFUL RANIBIZUMAB TREATMENT IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION IN CLINICAL SETTINGS , 2012, Retina.
[7] Martin F. Kraus,et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography , 2012, Optics express.
[8] Alan W. Stitt,et al. Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy. , 2004, The American journal of pathology.
[9] Phillip G Yuile,et al. Age‐related macular degeneration: a leading cause of blindness , 1997, The Medical journal of Australia.
[10] K. Sonoda,et al. A Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis , 2013, PloS one.
[11] U. Chakravarthy,et al. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Outcomes in Eyes With Poor Initial Vision , 2015, Retina.
[12] T. Hisatomi,et al. Establishment of a new animal model of focal subretinal fibrosis that resembles disciform lesion in advanced age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.
[13] H. Grossniklaus,et al. Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes. , 1998, American journal of ophthalmology.
[14] David Huang. Clinical Guide to Angio-OCT: Non Invasive, Dyeless OCT Angiography , 2014 .
[15] W. Cui,et al. Interleukin-6 receptor blockade suppresses subretinal fibrosis in a mouse model. , 2014, International journal of ophthalmology.
[16] K Bailey Freund,et al. Do We Need a New Classification for Choroidal Neovascularization in Age-Related Macular Degeneration? , 2010, Retina.
[17] John C. Hwang,et al. Development of subretinal fibrosis after anti-VEGF treatment in neovascular age-related macular degeneration. , 2011, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.
[18] C. Van Noorden,et al. The role of CTGF in diabetic retinopathy. , 2015, Experimental eye research.
[19] R. Spaide. Optical Coherence Tomography Angiography Signs of Vascular Abnormalization With Antiangiogenic Therapy for Choroidal Neovascularization. , 2015, American journal of ophthalmology.
[20] Martin F. Kraus,et al. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. , 2014, Ophthalmology.
[21] Jay S Duker,et al. Spectral-domain optical coherence tomography angiography of choroidal neovascularization. , 2015, Ophthalmology.
[22] P T de Jong,et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .
[23] M. Larsen,et al. Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab. , 2013, American journal of ophthalmology.
[24] T. Sjöblom,et al. Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. , 2004, Cancer research.
[25] Richard F Spaide,et al. Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography. , 2015, JAMA ophthalmology.
[26] N. Niles. Pathologic Basis of Disease , 1974 .
[27] P. Campochiaro,et al. Regression of choroidal neovascularization results in macular atrophy in anti-vascular endothelial growth factor-treated eyes. , 2015, American journal of ophthalmology.
[28] D. Brigstock,et al. Connective tissue growth factor: what's in a name? , 2000, Molecular genetics and metabolism.